Pharmaceutical Technology on MSN6d
Tribune gains funds to advance scar tissue therapiesTribune Therapeutics has secured €37m ($39.9m) in seed and Series A funding to propel its therapy portfolio aimed at the ...
Tribune Therapeutics AB has raised €37 million (US$40 million) in seed and series A funding to advance a portfolio of therapies targeting central drivers of scar tissue formation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback